Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slide: 19 of 37

Intermediate End Points and Health Outcomes in rhGH-Treated Patients With CF (1)

The studies of rhGH for patients with CF provide no evidence about the impact of treatment on long-term health and survival. It is important to understand how well intermediate end points of pulmonary function and anthropometrics predict important health outcomes, such as mortality and quality of life. To evaluate these relationships, results were compiled from studies that used regression analysis to these linkages in patients with CF.